Insurers supervising the health care of Medicaid patients repeatedly reject providers’ approval of care; individuals are more likely to develop dementia if they live in disadvantaged neighborhoods; a type of an immunity gene is found in people who test positive for COVID-19 but don’t develop symptoms.
Private health insurance companies contracted by Medicaid rejected millions of requests for care for low-income Americans with minimal oversight from federal and state authorities, according to a new report, according to The New York Times. The report released by the HHS inspector general’s office described how often private insurance plans denied treatment approval bids and how states handled these rebuts. Doctors claim that requirements of prior authorization usually just interfere with needed services. The report highlighted the vital role officials should play in making sure the denials are justified.
A study published in JAMA Neurology finds that Americans who reside in neighborhoods with less socioeconomic advantage might be at increased risk of dementia, reported STAT News. This can be the case no matter the individual’s background, with the study finding that people living in areas of the country with the lowest rates of income, education, employment, and housing quality possessed a 1.17 times higher risk of developing dementia compared with those living in the most prosperous areas.
Scientists have discovered a type of a specific gene that might explain why some people who test positive for COVID-19 never develop symptoms, according to The Washington Post. This finding could assist scientists with creating new vaccines and treatments. Studies have discovered that at least 20% of people who contract COVID-19 are asymptomatic, on average. Scientists think that these people might have more rapid immune responses to fight the virus before symptoms are established and lead to health issues.
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More